Podhalanski Szpital Specjalistyczny Im. Jana Pawla II W Nowym Targu
- Address
- Ul. Szpitalna 14, 34-400 Nowy Targ, Poland
Podhalanski Szpital Specjalistyczny Im. Jana Pawla II W Nowym Targu - Cardiovascular Research Center
The John Paul II Podhalanski Specialist Hospital in Nowy Targ is a dedicated cardiovascular research center with expertise in acute and chronic coronary conditions. The facility demonstrates significant experience in conducting advanced clinical trials focused on antiplatelet therapy strategies and lipid-lowering interventions for patients with cardiovascular disease.
- Acute Coronary Syndrome (ACS) management and antiplatelet de-escalation strategies
- Atherosclerotic cardiovascular disease (ASCVD) prevention and treatment
- Novel lipid-lowering therapies for secondary cardiovascular prevention
The center's research portfolio emphasizes optimization of dual antiplatelet therapy (DAPT) regimens and evaluation of innovative cardiovascular risk reduction strategies. Their participation in multinational trials investigating medications like ticagrelor and inclisiran demonstrates their commitment to advancing evidence-based approaches for preventing major adverse cardiovascular events, including cardiovascular death, myocardial infarction, and stroke in high-risk patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Podhalanski Szpital Specjalistyczny Im. Jana Pawla II W Nowym Targu
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| ARTEMIS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction. | Novo Nordisk A/S | Phase III | Not Recruiting | Aug 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2022-02-07 | 2022-02-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.